1. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea
- Author
-
Eun Lee, Chul-Hong Kim, Yong Ju Lee, Hyo-Bin Kim, Bong-Seong Kim, Hyung Young Kim, Yunsun Kim, Sangyoung Kim, Chorong Park, Ju-Hee Seo, In Suk Sol, Myongsoon Sung, Min Seob Song, Dae Jin Song, Young Min Ahn, Hea Lin Oh, Jinho Yu, Sungsu Jung, Kyung Suk Lee, Ju Suk Lee, Gwang Cheon Jang, Yoon-Young Jang, Eun Hee Chung, Hai Lee Chung, Sung-Min Choi, Yun Jung Choi, Man Yong Han, Jung Yeon Shim, Jin Tack Kim, Chang-Keun Kim, Hyeon-Jong Yang, and Pneumonia and Respiratory Disease Study Group of Korean Academy of Pediatric Allergy and Respiratory Disease
- Subjects
Children ,Pneumonia ,Respiratory virus ,Mycoplasma pneumoniae ,Macrolide- refractory ,Macrolide-sensitive ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Community–acquired pneumonia (CAP) is one of the leading worldwide causes of childhood morbidity and mortality. Its disease burden varies by age and etiology and is time dependent. We aimed to investigate the annual and seasonal patterns in etiologies of pediatric CAP requiring hospitalization. Methods We conducted a retrospective study in 30,994 children (aged 0–18 years) with CAP between 2010 and 2015 at 23 nationwide hospitals in South Korea. Mycoplasma pneumoniae (MP) pneumonia was clinically classified as macrolide-sensitive MP, macrolide-less effective MP (MLEP), and macrolide-refractory MP (MRMP) based on fever duration after initiation of macrolide treatment, regardless of the results of in vitro macrolide sensitivity tests. Results MP and respiratory syncytial virus (RSV) were the two most commonly identified pathogens of CAP. With the two epidemics of MP pneumonia (2011 and 2015), the rates of clinical MLEP and MRMP pneumonia showed increasing trends of 36.4% of the total MP pneumonia. In children
- Published
- 2020
- Full Text
- View/download PDF